143 related articles for article (PubMed ID: 34461111)
1. The implications of nitric oxide metabolism in the treatment of glial tumors.
Mazurek M; Rola R
Neurochem Int; 2021 Nov; 150():105172. PubMed ID: 34461111
[TBL] [Abstract][Full Text] [Related]
2. NOS Expression and NO Function in Glioma and Implications for Patient Therapies.
Tran AN; Boyd NH; Walker K; Hjelmeland AB
Antioxid Redox Signal; 2017 Jun; 26(17):986-999. PubMed ID: 27411305
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: A systematic review.
Merenzon MA; Hincapie Arias E; Bhatia S; Shah AH; Higgins DMO; Villaverde M; Belgorosky D; Eijan AM
Nitric Oxide; 2023 Sep; 138-139():10-16. PubMed ID: 37279819
[TBL] [Abstract][Full Text] [Related]
4. Adrenomedullin and nitric oxide: implications for the etiology and treatment of primary brain tumors.
Fernandez AP; Serrano J; Amorim MA; Pozo-Rodrigalvarez A; Martinez-Murillo R
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):820-33. PubMed ID: 21999731
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids.
Shen SC; Lin CW; Lee HM; Chien LL; Chen YC
Neuroscience; 2006 Jun; 140(2):477-89. PubMed ID: 16580779
[TBL] [Abstract][Full Text] [Related]
6. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
7. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.
Eyler CE; Wu Q; Yan K; MacSwords JM; Chandler-Militello D; Misuraca KL; Lathia JD; Forrester MT; Lee J; Stamler JS; Goldman SA; Bredel M; McLendon RE; Sloan AE; Hjelmeland AB; Rich JN
Cell; 2011 Jul; 146(1):53-66. PubMed ID: 21729780
[TBL] [Abstract][Full Text] [Related]
8. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
9. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
10. Malignant glioma progression and nitric oxide.
Lam-Himlin D; Espey MG; Perry G; Smith MA; Castellani RJ
Neurochem Int; 2006 Dec; 49(8):764-8. PubMed ID: 16971023
[TBL] [Abstract][Full Text] [Related]
11. Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells.
Kim RK; Suh Y; Cui YH; Hwang E; Lim EJ; Yoo KC; Lee GH; Yi JM; Kang SG; Lee SJ
Cancer Sci; 2013 Sep; 104(9):1172-7. PubMed ID: 23714583
[TBL] [Abstract][Full Text] [Related]
12. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
13. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
14. Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones.
Altinoz MA; Elmaci İ
Nitric Oxide; 2018 Sep; 79():68-83. PubMed ID: 29030124
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro.
Weyerbrock A; Baumer B; Papazoglou A
J Neurosurg; 2009 Jan; 110(1):128-36. PubMed ID: 18991497
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and glioma: a target for novel therapy?
Shinoda J; Whittle IR
Br J Neurosurg; 2001 Jun; 15(3):213-20. PubMed ID: 11478055
[TBL] [Abstract][Full Text] [Related]
17. Targeting iNOS As a Valuable Strategy for the Therapy of Glioma.
Maccallini C; Gallorini M; Cataldi A; Amoroso R
ChemMedChem; 2020 Feb; 15(4):339-344. PubMed ID: 31851765
[TBL] [Abstract][Full Text] [Related]
18. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
[TBL] [Abstract][Full Text] [Related]
19. Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.
Yao XH; Liu Y; Chen K; Gong W; Liu MY; Bian XW; Wang JM
Int Immunopharmacol; 2011 Dec; 11(12):1961-6. PubMed ID: 21930249
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.
Gu C; Banasavadi-Siddegowda YK; Joshi K; Nakamura Y; Kurt H; Gupta S; Nakano I
Stem Cells; 2013 May; 31(5):870-81. PubMed ID: 23339114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
